| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 |
CRISPR Therapeutics AG
CRSP
|
BUY |
$60.00
Est. +21%
|
$49.44 | $51.25 |
Pending
|
$49.80
+0.7%
|
| Mar 17, 2026 |
Bicycle Therapeutics Plc - ADR
BCYC
|
BUY |
$13.00
Est. +153%
|
$5.13 | $5.41 |
Pending
|
$4.05
-21.1%
|
| Mar 13, 2026 |
Sana Biotechnology Inc
SANA
|
BUY |
$12.00
Est. +257%
|
$3.36 | $4.08 |
Pending
|
$2.68
-20.2%
|
| Feb 12, 2026 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$256.00
Est. +16%
|
$221.49 | $250.74 |
Precision Hit (±3%)
|
$218.06
-1.5%
|
| Jan 09, 2026 |
Monopar Therapeutics Inc
MNPR
|
BUY |
$115.00
Est. +81%
|
$63.40 | $76.13 |
Pending
|
$59.77
-5.7%
|
| Jan 08, 2026 |
Cytokinetics Inc
CYTK
|
BUY |
$90.00
Est. +38%
|
$65.25 | $80.18 |
Pending
|
$70.15
+7.5%
|
| Jan 08, 2026 |
Insmed Inc
INSM
|
SELL |
$157.00
Est. +11%
|
$176.00 | $90.39 (Low) |
Target Met
|
$97.85
+44.4%
|
| Jan 08, 2026 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$50.00
Est. +107%
|
$24.20 | $27.40 |
Pending
|
$24.35
+0.6%
|
| Dec 04, 2025 |
Pharvaris NV
PHVS
|
BUY |
$41.00
Est. +40%
|
$29.37 | $33.29 |
Pending
|
$30.72
+4.6%
|
| May 05, 2025 |
Bicycle Therapeutics Plc - ADR
BCYC
|
BUY |
$17.00
Est. +88%
|
$9.06 | $9.36 |
Miss
|
$4.05
-55.3%
|
| Mar 26, 2024 |
Invivyd Inc
IVVD
|
BUY |
$10.00
Est. +210%
|
$3.23 | $2.74 |
Miss
|
$0.77
-76.2%
|